Answers are grounded in this paper and cite their sources.
A macrolide antimicrobial drug was administered to a newborn with cough. On day 23 of hospitalization, macrolide-resistant Bordetella pertussis was isolated from nasopharyngeal aspirates. DNA sequencing and PCR-restriction fragment length polymorphism showed a 2047 A-to-G mutation in the 3 copies of the 23S rRNA gene. Monitoring for macrolide resistance is essential in infants <6 months of age.
No takes yet. Share an insight, caveat, or question.
Guillot et al. (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: